A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma

NCT07240753NOT_YET_RECRUITINGOBSERVATIONAL

Summary

Key Facts

Lead Sponsor

Lili

Enrollment

200

Start Date

2025-12-01

Completion Date

2028-11-01

Study Type

OBSERVATIONAL

Official Title

Clinical Characteristics and Prognostic Factors of Large Cell Neuroendocrine Carcinoma of the Cervix: A Multicenter, Bidirectional Cohort Study

Interventions

Postoperative pathological examination confirmed cervical large cell neuroendocrine carcinoma.

Conditions

Uterine Cervical Neoplasms

Eligibility

Sex

FEMALE

Inclusion Criteria: The diagnosis of cervical large cell neuroendocrine carcinoma (LCNEC) was confirmed by histopathological examination, meeting both clinical and histological criteria. The tumor exhibited characteristic features, including large cells with abundant cytoplasm, vesicular nuclei with prominent nucleoli, and a high mitotic rate (\>10 mitoses/10 HPFs). The growth patterns were predominantly insular, trabecular, or solid, often accompanied by peripheral palisading or rosette formation, along with focal tumor necrosis.

\-

Exclusion Criteria: Mixed cervical LCNEC histology, cases with missing follow-up, or patients lost to contact.

\-

Outcome Measures

Primary Outcomes

Overall Survival

Time frame: One month post-enrollment completion and then annual follow-up

Disease Recurrence

Time frame: One month post-enrollment completion and then annual follow-up

A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma